McKesson: Re-Rated Again Amidst Increased M&A Efforts

McKesson, a major healthcare company, has been re-rated by analysts due to increased merger and acquisition efforts. The company's stock price has fluctuated in recent weeks.

The re-rating comes amidst speculation about potential deals, with some analysts suggesting that McKesson could be a target for acquisition.

The company has not made any official announcements regarding potential mergers or acquisitions.